
Italian antitrust authorities on Wednesday said it fined Swiss pharmaceutical companies Novartis and Roche over 180 million euros (247 million U.S. dollars). According to Italian new agency ANSA, the pharmaceutical companies were fined for allegedly colluding to manipulate the market in Italy. "The two companies made an illegal agreement to curtail the use of a very cheap pharmaceutical, (Roche's) Avastin, in the treatment of a widespread eye pathology among the elderly in favour of the expensive (Novartis's) Lucentis, artificially differentiating the two products," the antitrust statement read. The action cost the Italian national health service over 45 million euros in 2012 alone, the statement said, and additional costs in the future could potentially reach 600 million euros a year. Novartis and Roche have both said that the accusations were groundless and that they would appeal to administrative courts.
GMT 12:09 2018 Monday ,26 November
Black Friday less wild as more Americans turn to online dealsGMT 15:06 2018 Sunday ,18 November
Refugee host countries discuss UNRWA's financial crisisGMT 16:17 2018 Monday ,12 November
Egypt working on 4-year plan to increase growth rateGMT 12:45 2018 Friday ,09 November
Egyptian agriculture products introduced to Japanese markeGMT 11:42 2018 Friday ,02 November
Turkey's new mega airport, boon for slowing economyGMT 13:42 2018 Monday ,29 October
Egypt's trade volume hits $67.63 bln over 9 monthsGMT 15:13 2018 Friday ,12 October
Govt to announce incentives package for Overseas PakistanisGMT 14:46 2018 Thursday ,11 October
Economy and energy dominate agenda in Russian-Slovak relationsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor